Related Experiment Video

Updated: May 28, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after

Ze-peng Lin1, Ping-chun Shu, Zhi-jian Liao

  • 1Department of Cardiology, Sun Yat-sen Cardiovascular Hospital, Shenzhen, China. szlinzepeng@163.com

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|October 27, 2011
PubMed

Insights

Rosuvastatin significantly improved heart function and reduced artery thickness in ST-segment elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention (PCI). This statin therapy offers superior benefits compared to simvastatin for cardiovascular recovery.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Context:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring timely intervention.
  • Percutaneous coronary intervention (PCI) is a standard treatment for STEMI.
  • Assessing the long-term effects of statin therapy on myocardial function and atherosclerosis is crucial for patient outcomes.

Purpose:

  • To compare the efficacy of rosuvastatin versus simvastatin in patients with STEMI after PCI.
  • To evaluate the impact of these statins on myocardial function and arteriosclerosis plaque.
  • To assess changes in lipid profiles, inflammatory markers, and arterial wall thickness.

Summary:

  • Sixty-five STEMI patients received either simvastatin or rosuvastatin alongside conventional treatment for 12 months.
  • Measurements included lipid profiles, C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), echocardiography, and SPECT.
  • Rosuvastatin demonstrated more significant reductions in cholesterol, inflammatory markers, and intima-media thickness (IMT) compared to simvastatin.

Impact:

  • Rosuvastatin therapy significantly improved the function of the surviving myocardium.
  • Rosuvastatin effectively reduced intima-media thickness (IMT) of the common carotid artery, indicating plaque stabilization.
  • These findings suggest rosuvastatin is a beneficial therapeutic option for STEMI patients post-PCI, enhancing cardiovascular recovery and reducing atherosclerosis progression.
Abstract

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...